Logo image of REC.MI

RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Fundamental Analysis

Europe - BIT:REC - IT0003828271 - Common Stock

52.825 EUR
-0.17 (-0.33%)
Last: 9/17/2025, 3:29:18 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to REC. REC was compared to 49 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of REC while its profitability can be described as average. REC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

REC had positive earnings in the past year.
REC had a positive operating cash flow in the past year.
REC had positive earnings in each of the past 5 years.
REC had a positive operating cash flow in each of the past 5 years.
REC.MI Yearly Net Income VS EBIT VS OCF VS FCFREC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of REC (7.87%) is better than 67.35% of its industry peers.
REC has a Return On Equity of 21.77%. This is in the better half of the industry: REC outperforms 73.47% of its industry peers.
The Return On Invested Capital of REC (12.31%) is better than 63.27% of its industry peers.
REC had an Average Return On Invested Capital over the past 3 years of 12.56%. This is below the industry average of 15.25%.
Industry RankSector Rank
ROA 7.87%
ROE 21.77%
ROIC 12.31%
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
REC.MI Yearly ROA, ROE, ROICREC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 16.42%, REC is in the better half of the industry, outperforming 67.35% of the companies in the same industry.
In the last couple of years the Profit Margin of REC has declined.
REC has a better Operating Margin (26.76%) than 75.51% of its industry peers.
In the last couple of years the Operating Margin of REC has declined.
REC has a Gross Margin of 67.79%. This is comparable to the rest of the industry: REC outperforms 46.94% of its industry peers.
REC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.76%
PM (TTM) 16.42%
GM 67.79%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
REC.MI Yearly Profit, Operating, Gross MarginsREC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so REC is still creating some value.
REC has about the same amout of shares outstanding than it did 1 year ago.
REC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for REC is higher compared to a year ago.
REC.MI Yearly Shares OutstandingREC.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REC.MI Yearly Total Debt VS Total AssetsREC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.65 indicates that REC is not in any danger for bankruptcy at the moment.
REC has a Altman-Z score of 3.65. This is comparable to the rest of the industry: REC outperforms 55.10% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that REC has dependencies on debt financing.
REC's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. REC is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 3.65
ROIC/WACC1.69
WACC7.29%
REC.MI Yearly LT Debt VS Equity VS FCFREC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.47 indicates that REC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.47, REC is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that REC should not have too much problems paying its short term obligations.
REC has a Quick ratio (1.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.01
REC.MI Yearly Current Assets VS Current LiabilitesREC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

6

3. Growth

3.1 Past

REC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.75%, which is quite good.
REC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.74% yearly.
REC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.51%.
The Revenue has been growing by 9.58% on average over the past years. This is quite good.
EPS 1Y (TTM)10.75%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-10.39%
Revenue 1Y (TTM)11.51%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%11.43%

3.2 Future

The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
Based on estimates for the next years, REC will show a quite strong growth in Revenue. The Revenue will grow by 8.17% on average per year.
EPS Next Y13.02%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
EPS Next 5Y12.78%
Revenue Next Year13.6%
Revenue Next 2Y10.14%
Revenue Next 3Y8.87%
Revenue Next 5Y8.17%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REC.MI Yearly Revenue VS EstimatesREC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
REC.MI Yearly EPS VS EstimatesREC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.81, REC can be considered very expensive at the moment.
REC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of REC to the average of the S&P500 Index (27.20), we can say REC is valued inline with the index average.
A Price/Forward Earnings ratio of 16.75 indicates a correct valuation of REC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REC is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.71. REC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 26.81
Fwd PE 16.75
REC.MI Price Earnings VS Forward Price EarningsREC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as REC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.42
REC.MI Per share dataREC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.06
PEG (5Y)9.8
EPS Next 2Y13.22%
EPS Next 3Y11.89%

4

5. Dividend

5.1 Amount

REC has a Yearly Dividend Yield of 2.33%.
Compared to an average industry Dividend Yield of 3.04, REC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, REC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

The dividend of REC has a limited annual growth rate of 5.70%.
Dividend Growth(5Y)5.7%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

REC pays out 64.48% of its income as dividend. This is not a sustainable payout ratio.
REC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.48%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
REC.MI Yearly Income VS Free CF VS DividendREC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
REC.MI Dividend Payout.REC.MI Dividend Payout, showing the Payout Ratio.REC.MI Dividend Payout.PayoutRetained Earnings

RECORDATI INDUSTRIA CHIMICA

BIT:REC (9/17/2025, 3:29:18 PM)

52.825

-0.17 (-0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-29 2025-07-29
Earnings (Next)11-11 2025-11-11
Inst Owners28.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.05B
Analysts74.67
Price Target60.43 (14.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend1.23
Dividend Growth(5Y)5.7%
DP64.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.01%
PT rev (3m)2.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.69%
EPS NY rev (3m)-1.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 26.81
Fwd PE 16.75
P/S 4.46
P/FCF N/A
P/OCF 19.22
P/B 5.91
P/tB N/A
EV/EBITDA 15.42
EPS(TTM)1.97
EY3.73%
EPS(NY)3.15
Fwd EY5.97%
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)2.75
OCFY5.2%
SpS11.86
BVpS8.94
TBVpS-6.58
PEG (NY)2.06
PEG (5Y)9.8
Profitability
Industry RankSector Rank
ROA 7.87%
ROE 21.77%
ROCE 16.15%
ROIC 12.31%
ROICexc 13.4%
ROICexgc 85.95%
OM 26.76%
PM (TTM) 16.42%
GM 67.79%
FCFM N/A
ROA(3y)8.39%
ROA(5y)10.39%
ROE(3y)21.82%
ROE(5y)24.25%
ROIC(3y)12.56%
ROIC(5y)14.53%
ROICexc(3y)13.61%
ROICexc(5y)15.94%
ROICexgc(3y)107.06%
ROICexgc(5y)120.52%
ROCE(3y)16.51%
ROCE(5y)18.96%
ROICexcg growth 3Y-16.79%
ROICexcg growth 5Y-5.99%
ROICexc growth 3Y-13.14%
ROICexc growth 5Y-5.73%
OM growth 3Y-4.02%
OM growth 5Y-2.11%
PM growth 3Y-10.03%
PM growth 5Y-6.5%
GM growth 3Y-2.14%
GM growth 5Y-0.62%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA 2.54
Cap/Depr 464.32%
Cap/Sales 35.24%
Interest Coverage 7.76
Cash Conversion 67.5%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.01
Altman-Z 3.65
F-Score6
WACC7.29%
ROIC/WACC1.69
Cap/Depr(3y)284.95%
Cap/Depr(5y)216.99%
Cap/Sales(3y)19.98%
Cap/Sales(5y)14.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.75%
EPS 3Y3.03%
EPS 5Y2.74%
EPS Q2Q%-10.39%
EPS Next Y13.02%
EPS Next 2Y13.22%
EPS Next 3Y11.89%
EPS Next 5Y12.78%
Revenue 1Y (TTM)11.51%
Revenue growth 3Y14.01%
Revenue growth 5Y9.58%
Sales Q2Q%11.43%
Revenue Next Year13.6%
Revenue Next 2Y10.14%
Revenue Next 3Y8.87%
Revenue Next 5Y8.17%
EBIT growth 1Y11.3%
EBIT growth 3Y9.43%
EBIT growth 5Y7.27%
EBIT Next Year44.75%
EBIT Next 3Y18.7%
EBIT Next 5Y14.63%
FCF growth 1Y-168.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.39%
OCF growth 3Y5.01%
OCF growth 5Y12.33%